个人简介
Dr. Glover graduated from Queens University, Belfast (MB BCh BAO) in 1999 and after performing 3 years in internal medicine (MRCP, London, UK 2002) joined the cardiology programme in the Royal Victoria Hospital, Belfast. During this time he performed two years of research looking at various aspects of internal and transthoracic cardioversion for the treatment of atrial fibrillation. Following the submission of his thesis he gained his Doctorate of Medicine from the Queens University in 2006. As a result of this research he was awarded the Purce Calvert Medal, the British Junior Cardiology Association-Cordis International Research Awards for Invasive Cardiology, the Northern Ireland Chest Heart and Stroke prize and the Northern Ireland Healthcare Award for the innovative use of technology to improve Patient Care.
He spent several more years training in general cardiology and subsequently subspecialised in cardiac electrophysiology in Toronto General Hospital, Ontario from 2009 – 2011 where he trained in catheter ablations and device therapy as well as publishing data from the Epistry Registry on the use of antiarrhythmic drugs in the management of out of hospital cardiac arrest. He was also awarded an unrestricted research grant examining the use of anti arrhythmic drugs in the management of ventricular arrhythmias.
Following this, he returned to Ireland where he worked as a Cardiac Electrophysiologist in the Heart and Vascular Division, Mater Private Hospital and Bon Secours Healthcare Network. He continued to develop a specialised interest in the catheter ablation of atrial fibrillation and ventricular arrhythmias. He acted as the National Coordinator for the European Observational Registry Programme for Atrial Fibrillation Ablations (European Society of Cardiology) an published a book entitled ‘A Clinical Approach to Cardiac Arrhythmia (NSHI, 2011)’
He subsequently decided to return to Canada and was appointed Assistant Professor of Cardiology in July 2015.
He has a special interest in the management of atrial fibrillation and ventricular arrhythmias and is keen to continue to build the complex ablation programme in Kingston. He also has a keen interest in teaching and his research interests are principally focused on the development of new technologies for the management of arrhythmias.
He is a fellow of the European Society of Cardiology and Heart Rhythm Society and a member of the Canadian Cardiovascular Society, European Heart Rhythm Association and the Working Group on Cardiac Cellular Electrophysiology of the European Society of Cardiology.